Ann: Atomo and Access Bio renegotiate supply agreements, page-43

So you're complaining that they couldn't sell their RAT (a test they onsell) into the Australian market over the past 24 months when the regulatory landscape has only really facilitated material sales over the past 2 months....? Makes alot of sense :/

The statement that the company has mad no progress over 4 years is just nonsensical. They increased revenaue by 25% the past year, increased production capacity, and in my opinion are on the cusp of capitalising on RAT sales. Maybe if it's such a bad company why don't you cut your losses and move on? Surely still holding for a reason I'd say and you're probably just venting as it make you feel better of the red in your portfolio.